Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03916068 · ClinicalTrials.gov registry record · Phase 2
Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy
A Phase 2 study, sponsored by Legacy Health System.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT03916068 is a Phase 2 study that was terminated before completion, run by Legacy Health System. The registered enrollment target is 1 participants.
The verdict
NCT03916068, a Phase 2 study, was terminated before completion, sponsored by Legacy Health System.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study aims to compare patients that receive hyperbaric oxygen or Trental and Vitamin E immediately after completion of radiation therapy to evaluate which treatment best reduces radiation fibrosis.
Interventions
- DIETARY_SUPPLEMENT Vitamin E
- PROCEDURE Hyperbaric Oxygen Therapy
- DRUG Trental Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2023-10-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03916068
The ClinicalTrials.gov registry entry for NCT03916068 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Legacy Health System, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Vitamin E is the first listed.
NCT03916068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03916068 about?
NCT03916068 is a clinical study titled "Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy". This study aims to compare patients that receive hyperbaric oxygen or Trental and Vitamin E immediately after completion of radiation therapy to evaluate which treatment best reduces radiation fibrosis.
What is the current status of trial NCT03916068?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2019-07-01. Estimated completion is 2023-10-02.
What interventions are being tested in trial NCT03916068?
The interventions under investigation include: Vitamin E (DIETARY_SUPPLEMENT), Hyperbaric Oxygen Therapy (PROCEDURE), Trental Pill (DRUG).
Who is sponsoring clinical trial NCT03916068?
This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.